David Cornblath

Professor

1973 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where David Cornblath is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Medicine & Life Sciences
Peripheral Nervous System Diseases Medicine & Life Sciences
Guillain-Barre Syndrome Medicine & Life Sciences
Polyneuropathies Medicine & Life Sciences
Intravenous Immunoglobulins Medicine & Life Sciences
Neural Conduction Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Diabetic Neuropathies Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1973 2019

Current treatment practice of Guillain-Barré syndrome

IGOS Consortium, Jul 2 2019, In : Neurology. 93, 1, p. e59-e76

Research output: Contribution to journalArticle

Miller Fisher Syndrome
Therapeutics
Plasma Exchange
Intravenous Immunoglobulins
Bangladesh

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

on Behalf of the PRIMA Trial Investigators and the PATH Study Group, Mar 1 2019, In : Journal of the Peripheral Nervous System. 24, 1, p. 48-55 8 p.

Research output: Contribution to journalArticle

Open Access
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Polyneuropathies
Intravenous Immunoglobulins
Safety
Drug-Related Side Effects and Adverse Reactions

Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings

Argyriou, A. A., Park, S. B., Islam, B., Tamburin, S., Velasco, R., Alberti, P., Bruna, J., Psimaras, D., Cavaletti, G. & Cornblath, D., Jan 1 2019, In : Journal of Neurology, Neurosurgery and Psychiatry.

Research output: Contribution to journalReview article

Neural Conduction
Drug Therapy
Research
Spinal Ganglia
Nerve Fibers

Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity

the CI-PeriNomS Group, Mar 1 2019, In : Journal of the Peripheral Nervous System. 24, 1, p. 111-119 9 p.

Research output: Contribution to journalArticle

Physicians
Drug Therapy
Neurologic Examination
Vibration
Outcome Assessment (Health Care)

Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy

Bunschoten, C., Jacobs, B. C., Van den Bergh, P. Y. K., Cornblath, D. & van Doorn, P. A., Aug 1 2019, In : The Lancet Neurology. 18, 8, p. 784-794 11 p.

Research output: Contribution to journalReview article

Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Immunoglobulins
Therapeutics
Plasma Exchange
Neural Conduction